Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

Alogliptin helps stimulate the release of insulin ... of Metabolism and Endocrinology Products in the FDA’s Center for Drug Evaluation and Research. Nesina, Kazano, and Oseni were studied ...

A series of trials to fast-track treatments to slow or stop Parkinson's disease is gathering pace across the country.

The Amsler grid tests the condition of the center of the retina or "macula". It is a good test for screening for the development of "wet" macular degeneration in patients with "dry" macular ...

The Amsler grid is a good test for people with Macular Degeneration. The Amsler grid tests the condition of the center of the retina or "macula" ...

Type 2 diabetes and obesity are intimately linked; reduction of bodyweight improves glycemic control, mortality and morbidity. Treating obesity in the diabetic is hampered as some diabetic ...